Frontier Wealth Management’s Armata Pharmaceuticals ARMP Stock Holding History

Frontier Wealth Management’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,607	Closed	-$7K	–	309
2019 Q1	$7K	Hold	1,607	–	–	﹤0.01%	362
2018 Q4	$5K	Buy	1,607 +643	+67%	+$3.14K	﹤0.01%	365
2018 Q3	$14K	Hold	964	–	–	﹤0.01%	392
2018 Q2	$15K	Buy	+964	New	+$15.7K	﹤0.01%	380
2017 Q2	–	Sell	-286	Closed	-$17K	–	387
2017 Q1	$17K	Sell	286 -21	-7%	-$1.43K	﹤0.01%	395
2016 Q4	$19K	Buy	+307	New	+$38.2K	﹤0.01%	397

Other funds holding ARMP

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

GWM

Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Frontier Wealth Management's ARMP Position: Q2 2019 in Review

Frontier Wealth Management sold out of Armata Pharmaceuticals (ARMP) in Q2 2019, closing a stake of 1,607 shares — an estimated $7K sold.

Frontier Wealth Management first reported a position in ARMP in Q4 2016 and held it in 6 quarters. The position peaked at $19K in Q4 2016. 12 funds tracked by Wall St. Rank hold ARMP as of Q2 2019.

Frontier Wealth Management reported no remaining Armata Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Frontier Wealth Management sold 1,607 Armata Pharmaceuticals shares in Q2 2019, an estimated $7K.
Frontier Wealth Management first reported a position in Armata Pharmaceuticals in Q4 2016 and held it in 6 quarters.
Frontier Wealth Management's Armata Pharmaceuticals position peaked at $19K in Q4 2016.
12 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2019.

Based on Frontier Wealth Management's 13F filing for Q2 2019, filed 16 Aug 2019.